This trial is testing the safety and effectiveness of an investigational drug to see if it works in treating a specific cancer. The drug, pertuzumab, is being studied in combination with paclitaxel and trastuzumab as a preoperative treatment for inflammatory breast cancer.
2 Primary · 8 Secondary · Reporting Duration: 63 months
23 Total Participants · 1 Treatment Group
Primary Treatment: Doxorubicin · No Placebo Group · Phase 2
Age 18+ · All Participants · 5 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: